Serum Institute of India

30 per cent survey respondents say they observed or experienced some irregularities on the ground like false certification to…

Also asks SII, Bharat Biotech to disclose COVID-19 vaccine capacity, as there 'has to be sense of responsibility, urgency'

India will begin immunising the public from next month, starting with those over 50 or with medical conditions

AstraZeneca hopes that in the first half of 2021, more than 300 million doses of the vaccine will be made available to 145…

Dr Abdul Ghafur, Coordinator, Chennai Declaration on AMR and Consultant in Infectious Diseases, Apollo Hospital, Chennai explains…

SII had earlier indicated that they were capable of supplying a few million doses of Covishield per week

Pneumosil is similar as the paediatric pneumococcal vaccine already on the market and targets serotypes 1, 5, 6A, 6B, 7F, 9V, 14,…

Panned for threatening affected participant with a Rs 100 crore defamation suit

Also collaborating on Novavax' COVOVAX, to apply for phase 3 trial approval soon

Dhanashree Bapat (Assistant Manager, Pharma) Business Research & Advisory, Aranca writes on how will a COVID–19 vaccine impact…